Preparation and Evaluation of New Composite Coating Based on Sodium Alginate and Heparin with Aldehyde Groups
1 Department of Heart Center, The Third Central Hospital, Tianjin 300170, China
2 Graduate School of Tianjin Medical University, Tianjin 300070, China
3 Key Laboratory of Artificial Cells , Tianjin 300170, China
Abstract:The aim of this work is to prepare a new composite coating based on sodium alginate and heparin with aldehyde groups, and to evaluate the biocompatibility and hemocompatibility of extracorporeal circulation loop. The loop samples were divided into four groups: (1) blank control (C), (2) sodium alginate (OSA), (3) heparin (LMNH), and (4) sodium alginate plus heparin (OSA.LMNH). The OSA and LMNH were bound to the surface of extracorporeal circulation loop by covalent linkage. Qualitative and quantitative analysis of polysaccharide fragments were conducted with FTIR and UV spectroscopy, the hemocompatibility of coated loop was evaluated by platelet adhesion, coagulation examination and protein adhesion, the hydrophily of coated loop was evaluated by surface contact angle. Experimental results showed that the surface of extracorporeal circulation loop was coated with OSA and LMNH. The platelet adhesion and thrombosis for the coated group were both decreased significantly compared with the noncoated group (P<0.05). The protein adhesion of LMNH group has no significantly difference with the noncoated group. The protein adhesion of OSA group and OSA.LMNH group significantly decreased compared with LMNH group (P<0.05). The anticoagulant property of LMNH group and OSA.LMNH group is good with significantly prolonged time of APTT and TT. The APTT time of OSA group is significantly prolonged compared with C group (p<0.05). The surface contact angles of OSA and OSA.LMNH group is significantly decreased compared with C group(p<0.05). The surface contact angle of LMNH group has no significantly difference with C group. Composite coating of polysaccharide fragments has improved anticoagulant property in reference to the control, and the hemocompatibility of the composite coating was obviously improved compared with single coating.
[1]RApostolakis EE, Koletsis EN, Baikoussis NG, et al. Strategies to prevent intraoperative lung injury during cardiopulmonary bypass[J]. J Cardiothorac Sury,2010,11(5):1.
[2]Suzuki Y, Daitoku K, Minakawa M, et al. Poly2methoxyethylacrylatecoated bypass circuits reduce activation of coagulation system and inflammatory response in congenital cardiac surgery[J]. J Artif Organs,2008,11(3):111-116.
[3]FinneWistrand A, Albertsson AC, Kwon OH, et al. Resorbable scaffolds from three different techniques: electrospun fabrics, saltleaching porous films, and smooth flat surfaces[J]. Macromol Biosci,2008,8(10):951-959.
[4]Sperling C,Houska M, Brynda E, et al. In vitro
hemocompatibility of albuminheparin multilayer coatings on polyethersulfone prepared by the layerbylayer technique[J]. J Biomed Mater Res, 2006,76(4):681-689.
[5]WeberN, Wendel P, Ziemer G. Hemocompatibility of heparincoated surfaces and the role of selective plasma protein adsorption[J]. Biomaterials, 2002, 23(2): 429-439.
[6]柏淑颖,朱德明,王伟. 涂层技术在体外循环装置中的应用及意义 [J]. 中国体外循环杂志,2009,7(2):124-128.
[7]Larm O, Larsson R, Olsson P. A new nonthrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue[J]. Biomater Med Devices Artif Organs, 1983,11(2-3):161-234.
[8]Andersson LO, Hoffman J,et al. Mechanisms of anticoagulant effects of some sulphated polysaccharides[J]. Thromb Res,1982,28(6):741-748.
[9]Smith PK, Mallia AK, Hermanson GT. Colorimetric method for the assay of heparin content in immobilized heparin preparations [J]. Analytical Biochemistry, 1980, 109(2):466-473.
[10]Dubois M,Gilles KA,Hamilton JK,et al. Colorimetric method for determination of sugars and related substances[J].Analytical Chemistry, 1956, 28(3) : 350-356.
[11]Ishihara K, Fukumoto K, Iwasaki Y, et al. Modification of polysulfone with phospholipid polymer for improvement of the blood compatibility. Part 1. Surface characterization[J].Biomaterials 1999, 20(17):1545–1551.
[12]Gunaydin S. Clinical significance of coated extracorporeal circuits: a review of novel technologies [J].Perfusion, 2004,19(1):33-41.
[13]Petitou M, Barzu T, Herault JP et al. A unique trisaccharide sequence in heparin mediates the early step of antithrombin IIactivation[J].Glycobiology,1997,7(3):323-327.
[14]Santerre JP,Woodhouse K,Laroche G,et al. Understanding the biodegradation of polyurethanes: from classical implants to tissue engineering materials[J]. Biomaterials, 2005,26(35): 7457-7470.
[15]Jeffrey FW, Wielders SJ, Willems GM, et al. Thrombogenicity of polysaccharidecoated surfaces[J]. Biomaterials, 2003, 24(11):1917-1924.
[16]Nishino T, Yokoyama G, Dobashi K, et al. Isolation, purification, and characterization of fucosecontaining sulfated polysaccharides from the brown seaweed Ecklonia kurome and their bloodanticoagulant activities [J]. Carbohydr Res, 1989,186(1):119-148.
[17]Manju S, Muraleedharan CV. Evaluation of alginate dialdehyde crosslinked gelatin hydrogel as a biodegradable sealant for polyester vascular graft[J]. J Biomed Mater Res B Appl Biomater, 2011 ,98(1):139-188.
[18]王琴梅,张亦霞,李卓萍,等. 多醛基海藻酸钠交联剂的制备及性能 [J]. 应用化学, 2010,27(2):155-158.
[19]Bouhadir KH, Lee KY, Alsberg E, et al. Degradation of partially oxidized alginate and its potential application for tissue engineering [J]. Biotechnol Prog,2001 ,17(5):945-995.